The Impact of Technology on Current Diabetes Management

Katharine Garvey; Joseph I Wolfsdorf

doi:10.1016/j.pcl.2015.04.005

The Impact of Technology on Current Diabetes Management

Pediatr Clin North Am. 2015 Aug;62(4):873-88. doi: 10.1016/j.pcl.2015.04.005. Epub 2015 May 16.

Authors

Katharine Garvey¹, Joseph I Wolfsdorf²

Affiliations

¹ Division of Endocrinology, Department of Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA. Electronic address: katharine.garvey@childrens.harvard.edu.
² Division of Endocrinology, Department of Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA.

PMID: 26210622
DOI: 10.1016/j.pcl.2015.04.005

Abstract

Technological innovations have revolutionized the treatment of type 1 diabetes. Although technological advances can potentially improve diabetes outcomes, maintenance of target glycemic control, at the present time, remains largely dependent on patient and family motivation, competence, and adherence to daily diabetes care requirements. Trials of closed loop or "artificial pancreas" technology show great promise to automate insulin delivery and achieve near normal glucose control and reduced hypoglycemia with minimal patient intervention.

Keywords: Adolescents; Artificial pancreas; Children; Continuous glucose monitoring; Insulin analogues; Insulin pump; Technology; Type 1 diabetes mellitus.

Publication types

Review

MeSH terms

Blood Glucose Self-Monitoring
Child
Diabetes Mellitus, Type 1 / therapy*
Diffusion of Innovation
Humans
Hypoglycemic Agents / administration & dosage
Insulin / administration & dosage
Insulin Infusion Systems
Monitoring, Ambulatory
Pancreas, Artificial

Substances

Hypoglycemic Agents
Insulin